Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Fielmann Group AGXSWX:FIE 84 Earnings Yield (Joel Greenblatt) % is 8.65% as of Mar. 2026, which is 77% above its 10-year median of 4.90. GuruFocus rates XSWX:FIE with a GF Score™ of 84/100 and a GF Value™ of CHF49.97. The stock has 2 warning signs investors should review. Among 852 Medical Devices & Instruments companies, Fielmann Group AG ranks better than 84.51% on this metric.
Fielmann Group AG's Enterprise Value for the quarter that ended in Mar. 2026 was CHF3,300 Mil.
Fielmann Group AG's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was CHF294 Mil. Fielmann Group AG's Earnings Yield (Joel Greenblatt) for the quarter that ended in Mar. 2026 was 8.65%.
The historical rank and industry rank for Fielmann Group AG's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
XSWX:FIE'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: 2.82 Med: 4.9 Max: 9.42
Current: 7.9
During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of Fielmann Group AG was 9.42%. The lowest was 2.82%. And the median was 4.90%.
XSWX:FIE's Earnings Yield (Joel Greenblatt) % is ranked better than 84.51% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 0.83
vs XSWX:FIE: 7.90
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Fielmann Group AG's Forward Rate of Return (Yacktman) % for the quarter that ended in Mar. 2026 was 8.45%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Fielmann Group AG (XSWX:FIE) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
Fielmann Group AG Earnings Yield (Joel Greenblatt) % Related Terms
Fielmann Group AG Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Fielmann Group AG's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fielmann Group AG Earnings Yield (Joel Greenblatt) % Chart
For the Medical Instruments & Supplies subindustry, Fielmann Group AG's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fielmann Group AG Earnings Yield (Joel Greenblatt) % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fielmann Group AG's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Fielmann Group AG's Earnings Yield (Joel Greenblatt) % falls into.
Fielmann Group AG Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Fielmann Group AGs Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2025 is calculated as
Fielmann Group AG's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF294 Mil.
What does a Earnings Yield (Joel Greenblatt) % of 8.65% mean?
Fielmann Group AG (XSWX:FIE) has a Earnings Yield (Joel Greenblatt) % of 8.65% as of Mar. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Fielmann Group AG and its competitors. This is 77% above median its historical median of 4.90. Over the past decade, Fielmann Group AG's Earnings Yield (Joel Greenblatt) % has ranged from 2.82 to 9.42. According to the industry distribution chart, Fielmann Group AG ranks #132 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 15.5%.
Is Fielmann Group AG's Earnings Yield (Joel Greenblatt) % too high?
Fielmann Group AG's current Earnings Yield (Joel Greenblatt) % of 8.65% is 77% above median its 10-year median of 4.90. Over the past 10 years, this metric has ranged from a low of 2.82 to a high of 9.42. The Medical Devices & Instruments industry median Earnings Yield (Joel Greenblatt) % is 0.83. Fielmann Group AG's value of 8.65% is 942.2% above this industry median. Based on the distribution chart, Fielmann Group AG ranks #132 out of 852 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Fielmann Group AG has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does Fielmann Group AG's Earnings Yield (Joel Greenblatt) % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Fielmann Group AG ranks #132 out of 852 companies for Earnings Yield (Joel Greenblatt) %. This places Fielmann Group AG in the top 16% of its industry — outperforming the majority of peers. The industry median Earnings Yield (Joel Greenblatt) % is 0.83. Fielmann Group AG's value of 8.65% is 942.2% above this benchmark. Historically, Fielmann Group AG's own Earnings Yield (Joel Greenblatt) % has ranged from 2.82 to 9.42 over the past decade. While the company's 10-year median is 4.90 vs. the industry median of 0.83, Fielmann Group AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median Earnings Yield (Joel Greenblatt) % among Medical Devices & Instruments companies is 0.83, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fielmann Group AG's current Earnings Yield (Joel Greenblatt) % of 8.65% is 942.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Fielmann Group AG and its competitors. For the Medical Devices & Instruments industry, the median Earnings Yield (Joel Greenblatt) % is 0.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fielmann Group AG's current Earnings Yield (Joel Greenblatt) % is 8.65%, which is 77% above median its own 10-year median of 4.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fielmann Group AG stock overvalued right now?
Fielmann Group AG (XSWX:FIE) has a current Earnings Yield (Joel Greenblatt) % of 8.65%. The stock's GF Value™ is CHF49.97, compared to a current price of CHF37.15 — trading 25.7% below its estimated fair value. The current Earnings Yield (Joel Greenblatt) % is 8.65%, which is 77% above median its 10-year median of 4.90 and 942.2% above the Medical Devices & Instruments industry median of 0.83. Fielmann Group AG's overall GF Score™ is 84/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For Fielmann Group AG (XSWX:FIE), the current Earnings Yield (Joel Greenblatt) % is 8.65% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fielmann Group AG (XSWX:FIE) Overvalued in 2026?
Based on GuruFocus' analysis, Fielmann Group AG stock appears to be undervalued.
The current stock price of CHF37.15 is trading 25.7% below its estimated GF Value™ of CHF49.97.
Key valuation signals for XSWX:FIE:
Earnings Yield (Joel Greenblatt) %: 8.65% (77% above median its 10-year median of 4.90)
GF Value™: CHF49.97 vs. price of CHF37.15 (25.7% below fair value)
Industry Position: 942.2% above the Medical Devices & Instruments median (#132 of 852)
No single metric tells the full story. See the XSWX:FIE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fielmann Group AG is involved in the purchase and sale of goods, in physical stores as well as wholesale and online, particularly in the optometric and hearing acoustics sectors, and especially sales of all kinds of vision aids - particularly glasses, eyeewear frames and lenses, sunglasses, contact lenses, accessories, hearing systems, as well as personal protective equipment. Fielmann is involved in all levels of the optical industry value-added chain: designing, manufacturing, product offering, and optician services. The group was divided into six segments: Germany, Switzerland, Austria, Spain, North America, and Other. The majority of its revenue is generated from Germany.
84GF Score
Get the complete analysis for XSWX:FIE
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:FIE has been successfully added to your 
